# Charité Universitätsmedizin Berlin Institut für Klinische Pharmakologie und Toxikologie

> research institute

**Wikidata**: [Q101254541](https://www.wikidata.org/wiki/Q101254541)  
**Source**: https://4ort.xyz/entity/charite-universitatsmedizin-berlin-institut-fur-klinische-pharmakologie-und-toxikologie

## Summary
Charité Universitätsmedizin Berlin Institut für Klinische Pharmakologie und Toxikologie is a research institute focused on clinical pharmacology and toxicology that operates as part of the Charité medical university system in Berlin, Germany, dedicated exclusively to conducting systematic scientific investigation without the dual responsibilities of teaching or commercial applications.

## Key Facts
- Classified as a research organization under the German National Library (GND ID: 4017909-6) and Library of Congress authority ID (sh85113043)
- Part of Charité Universitätsmedizin Berlin, a major academic medical center
- Located in Berlin, Germany (identified by Geonames feature code S.ITTR)
- Uses Dewey Decimal Classification 001.406 for library cataloging
- Recognized as a research institute across 41 Wikipedia language editions
- Has Ringgold ID 72123 for academic identification
- Operates exclusively for research purposes, distinguishing it from hybrid educational or commercial organizations

## FAQs
### Q: What is the primary function of this institute compared to university departments?
A: While university departments balance teaching and research, this institute exists solely to conduct systematic investigation in clinical pharmacology and toxicology, without degree-granting responsibilities or commercial objectives.

### Q: How does this institute differ from specialized pharmaceutical companies?
A: Unlike companies focused on drug development for profit, this research institute pursues fundamental scientific inquiry across all disciplines, with resources dedicated exclusively to knowledge generation rather than commercial applications.

### Q: What specific research areas does this institute focus on?
A: The institute specializes in clinical pharmacology and toxicology, conducting systematic investigation in drug metabolism, adverse effects, and therapeutic applications without the dual obligations of teaching or profit generation.

## Why It Matters
This research institute represents a critical component of Berlin's academic medical infrastructure, providing dedicated resources for fundamental scientific inquiry that might not fit within university or corporate timelines. By concentrating exclusively on research, it accelerates breakthroughs in understanding drug interactions, toxicological effects, and therapeutic applications, contributing to medical advancements that address global health challenges. The institute serves as a specialized engine of discovery focused on the safety and efficacy of pharmaceuticals, supporting evidence-based medical practice and drug development.

## Notable For
- Dedicated exclusively to research activities in clinical pharmacology and toxicology
- Operates as a standalone research entity rather than a sub-unit within larger organizations
- Classified with unique identifiers across multiple library and knowledge systems
- Recognized globally through 41 Wikipedia language editions
- Maintains independence from teaching obligations that typically divide university researchers' attention
- Provides specialized expertise in drug safety and therapeutic applications

## Body
### Classification and Identification
The Charité Universitätsmedizin Berlin Institut für Klinische Pharmakologie und Toxikologie is formally classified under multiple knowledge organization systems. The German National Library assigns it GND ID 4017909-6, while the Library of Congress uses authority ID sh85113043. Geographic databases recognize it through the Geonames feature code S.ITTR. In library science, it falls under Dewey Decimal Classification 001.406.

The institute is operationally distinct from scientific societies or learned societies which are membership-based organizations. Unlike think tanks focused on policy research, this institute pursues fundamental inquiry across all fields of clinical pharmacology and toxicology. It differs from research centers which may be sub-units within larger organizations rather than standalone entities.

The entity achieves broad international recognition, with Wikipedia articles in 41 languages including Arabic, Bengali, Catalan, Czech, German, Spanish, and others. This extensive linguistic coverage indicates the universal applicability and recognition of specialized research institutes as organizational forms across diverse cultural and national contexts.

### Research Focus and Scope
The institute specializes exclusively in clinical pharmacology and toxicology, conducting systematic investigation into drug metabolism, adverse effects, therapeutic applications, and safety profiles. Its research activities are concentrated on understanding how pharmaceuticals interact with biological systems and how toxic substances affect human health.

The institute operates without the dual responsibilities that typically divide university researchers' attention. Unlike departments within medical schools that must balance teaching undergraduate and graduate students with research, this research institute can pursue long-term, high-risk investigations that might not fit within academic or corporate timelines. This independence allows researchers to focus exclusively on generating new knowledge through systematic investigation.

### Institutional Relationships
The institute is part of Charité Universitätsmedizin Berlin, one of Europe's leading academic medical centers. This affiliation provides access to extensive resources including patient populations, clinical facilities, and collaborative networks within the university system. The relationship with Charité ensures the institute benefits from the university's academic infrastructure while maintaining its research-focused mission.

The institute maintains connections with global research networks through its participation in international scientific societies and collaborations. Its research outputs are disseminated through peer-reviewed publications in specialized journals, contributing to the body of knowledge in clinical pharmacology and toxicology.

### Global Recognition and Impact
Through its participation in 41 Wikipedia language editions, the institute demonstrates its global relevance and recognition as a specialized research entity. This widespread coverage indicates that the concept of specialized research institutes in clinical pharmacology and toxicology has achieved universal understanding across different cultural and linguistic contexts.

The institute's research contributes to evidence-based medical practice by providing critical data on drug safety and efficacy. Its findings influence clinical guidelines, regulatory decisions, and pharmaceutical development processes, ultimately impacting patient care and public health outcomes.

### Research Methods and Approach
The institute employs systematic investigation methods including clinical trials, laboratory research, and epidemiological studies to examine pharmacological effects and toxicological mechanisms. Researchers utilize advanced analytical techniques and computational models to analyze drug interactions and adverse effects.

The institute maintains independence from commercial interests, ensuring research is conducted without conflicts of interest that might influence findings. This independence allows for unbiased investigation into pharmaceutical safety and efficacy, contributing to the integrity of medical knowledge.

### Future Directions
The institute continues to expand its research focus to include emerging areas such as personalized medicine, pharmacogenomics, and novel therapeutic approaches. Its long-term research programs address complex problems in drug development and safety that require sustained investigation beyond typical academic or corporate timelines.

The institute's commitment to fundamental scientific inquiry positions it as a critical component of the global research infrastructure, contributing to breakthroughs that address pressing health challenges and advance medical knowledge.

## References

1. Aligned ISNI and Ringgold identifiers for institutions